250 related articles for article (PubMed ID: 25909634)
1. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.
Jiang X; Mei X; Feng D; Wang X
PLoS One; 2015; 10(4):e0122171. PubMed ID: 25909634
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
Green H; Paul M; Vidal L; Leibovici L
Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy.
Hashimoto K; Kobayashi Y; Asakura Y; Mori M; Azuma T; Maruyama D; Kim SW; Watanabe T; Tobinai K
Leuk Lymphoma; 2010 Oct; 51(10):1816-21. PubMed ID: 20919860
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Stern A; Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
[TBL] [Abstract][Full Text] [Related]
5. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
[TBL] [Abstract][Full Text] [Related]
7. Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.
Kurokawa T; Kaya H; Yoshida T
J Clin Exp Hematop; 2010; 50(2):159-62. PubMed ID: 21123974
[TBL] [Abstract][Full Text] [Related]
8. Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome.
Sato M; Ito S; Ogura M; Kamei K; Miyairi I; Miyata I; Higuchi M; Matsuoka K
Pediatr Nephrol; 2013 Jan; 28(1):145-9. PubMed ID: 22948319
[TBL] [Abstract][Full Text] [Related]
9. [Pneumocystis pneumonia prophylaxis with low-dose trimethoprim/sulfamethoxazole during rituximab-containing chemotherapy].
Shimizu R; Sakemura R; Iwata S; Hayakawa H; Miyao K; Kajiguchi T
Rinsho Ketsueki; 2019; 60(5):365-371. PubMed ID: 31167996
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii pneumonia in kidney transplantation.
Goto N; Oka S
Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Lee JY; Kang M; Suh KJ; Kim JW; Kim SH; Kim JW; Kim YJ; Song KH; Kim ES; Kim HB; Lee KW; Kim JH; Bang SM; Lee JS; Lee JO
Mycoses; 2021 Jan; 64(1):60-65. PubMed ID: 32970331
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
14. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
19. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.
Lim PL; Zhou J; Ditangco RA; Law MG; Sirisanthana T; Kumarasamy N; Chen YM; Phanuphak P; Lee CK; Saphonn V; Oka S; Zhang F; Choi JY; Pujari S; Kamarulzaman A; Li PC; Merati TP; Yunihastuti E; Messerschmidt L; Sungkanuparph S;
J Int AIDS Soc; 2012 Jan; 15(1):1. PubMed ID: 22281054
[TBL] [Abstract][Full Text] [Related]
20. Incidence, clinical presentation, and outcomes of
Barreto JN; Thompson CA; Wieruszewski PM; Pawlenty AG; Mara KC; Potter AL; Tosh PK; Limper AH
Leuk Lymphoma; 2020 Nov; 61(11):2622-2629. PubMed ID: 32623928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]